日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multi-omics dynamic profiling reveals predictive biomarkers for first-line immunochemotherapy in extensive-stage small-cell lung cancer

多组学动态分析揭示广泛期小细胞肺癌一线免疫化疗的预测性生物标志物

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07778-y
Zheng, Liang; Xu, Haoming; Wang, Shuyuan; Ma, Meili; Hu, Fang; Cheng, Lei; Lu, Jun; Pan, Feng; Zhang, Bo; Xu, Jianlin; Li, Ying; Shen, Yinchen; Zhang, Wei; Zhong, Runbo; Chu, Tianqing; Han, Baohui; Zheng, Xiaoxuan; Zhong, Hua; Nie, Wei; Zhang, Xueyan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Graph convolutional network-derived pathomics and clinical integration for predicting chemoimmunotherapy response in advanced lung squamous cell carcinoma: a multicenter study

基于图卷积网络的病理组学及临床整合预测晚期肺鳞状细胞癌化疗免疫治疗反应：一项多中心研究

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07962-0
Wang, Dongying; Mu, Shuai; Zhang, Minghui; Tao, Guangyu; Wang, Shuyuan; Shen, Yinchen; Xiao, Guanxi; Zhang, Xueyan; Cheng, Lei; Han, Baohui; Zhong, Hua; Nie, Wei
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Expert consensus on clinical practice for detecting fusion genes in non-small cell lung cancer using RNA-based next-generation sequencing

关于利用基于RNA的下一代测序技术检测非小细胞肺癌融合基因的临床实践的专家共识

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003967
Zhong, Hua; Han, Baohui
肺癌
肿瘤
肿瘤免疫
Sequencing
细胞生物学
发表日期：2026
文献求助 收藏

Patient preference for first-line treatments of ALK-positive metastatic non-small cell lung cancer: a discrete choice experiment

ALK阳性转移性非小细胞肺癌患者对一线治疗方案的偏好：一项离散选择实验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15509-7
Shao, Jiachen; Zhang, Bo; Yang, Shuhan; Jin, Ping; Zu, Dongmei; Hsu, Karina Chin Po; Li, Shunping; Han, Baohui
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2026
文献求助 收藏

Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial

鞘内注射培美曲塞和贝伐单抗治疗伴有软脑膜转移的非小细胞肺癌（NSCLC）患者的安全性和有效性：一项单臂、前瞻性、Ia期试验方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2026-116187
Kuang, Yanbin; Teng, Jiajun; Wang, Weimin; Zhang, Bo; Cheng, Lei; Zhang, Yao; Liu, Wanting; Gao, Zhiqiang; Nie, Wei; Xiong, Liwen; Shi, Chunlei; Zhang, Wei; Lou, Yuqing; Han, Baohui; Zhong, Hua
肺癌
肿瘤
肿瘤免疫
神经科学
CLC
细胞生物学
发表日期：2026
文献求助 收藏

Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

MEK/RTK通路共抑制对KRAS突变型非小细胞肺癌具有很高的治疗效果

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02382-w
Lu Jun, Hu Minjuan, Zhao Yikai, Chu Tianqing, Zhang Wei, Zhou Yijia, Cai Xinlei, Wu Jun, Hu Liang, Shi Chunlei, Xiong Liwen, Gu Aiqin, Wang Huimin, Zhang Yanwei, Lou Yuqing, Zhong Runbo, Gao Zhiqiang, Liu Hongyu, Zhou Chao, Wu Yingli, Zhu Liang, Zhong Hua, Ji Hongbin, Han Baohui
细胞生物学
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of first-line sintilimab plus anlotinib versus chemotherapy for metastatic non-small cell lung cancer: a phase II, open-label, randomized controlled trial

一线信迪利单抗联合安罗替尼对比化疗治疗转移性非小细胞肺癌的疗效和安全性：一项II期、开放标签、随机对照试验

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12654
Chu, Tianqing; Zhong, Hua; Yu, Zhuang; Wang, Jing; Zhao, Yanqiu; Mu, Xiaoqian; Yu, Xinmin; Shi, Xun; Shi, Qingming; Guan, Maojing; Ding, Cuimin; Geng, Nan; Qian, Jialin; Han, Baohui
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Noscapine derivative 428 suppresses ferroptosis through targeting GPX4.

诺斯卡品衍生物 428 通过靶向 GPX4 抑制铁死亡

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2025.103635
Zhang Youping, Shi Haoliang, Wang Yingying, Liu Wanting, Li Guanyi, Li Defeng, Wu Wenxuan, Wu Yunzhao, Zhang Ziwei, Ji Yanjie, Zhu Chujiao, Bai Wenhui, Lei Hu, Xu Hanzhang, Zhong Hua, Han Baohui, Yang Li, Liu Ligen, Wang Wei, Zhao Yaxue, Zhang Yongqiang, Wu Yingli
信号转导
铁死亡
发表日期：2025
文献求助 收藏

WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRAS(G12C)-mutant lung cancer.

WEE1 抑制剂通过 MYBL2-RRM2 轴与 KRAS G12C 抑制剂在 KRAS(G12C) 突变型肺癌中发挥协同作用

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07992-4
Zhou Chao, Liu Yuqing, Liu Hongyu, Lu Jun, Zhang Bo, Zhu Liang, Wang Shuyuan, Lei Huimin, Han Baohui
肿瘤
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer.

安罗替尼通过抑制 c-Myc/ORC2 轴增强 KRAS-G12C 抑制剂在非小细胞肺癌中的疗效

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07687-w
Liu Hongyu, Zhou Chao, Lu Jun, Liu Yuqing, Zou Peichen, Zhu Liang, Lei Huimin, Han Baohui
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏